Vanderbilt University School of Medicine

Jagasia, Madan , M.D.
Professor of Medicine

Lab Url: N/A

Phone Number: (615) 936-1803

Email Address:madan.jagasia@vanderbilt.edu

Jagasia, Madan's picture

Office Address   Mailing Address

2665 TVC, 1301 22nd Avenue, South, Nashville, TN 37232-5505

2665 TVC 37232-5505


Research Keywords
Hematologic malignancies, leukemia, lymphoma, stem cell transplantation,Cancer

Research Specialty
Stem cell transplant, leukemia, lymphoma, myeloma

Research Description
Clinical trials in GVHD, new drugs in leukemia, lymphoma and myeloma. Novel preparative regimen for stem cell transplant.

Publications
Jagasia, M, Greinix, H, Robin, M, Das-Gupta, E, Jacobs, R, Savani, BN, Engelhardt, BG, Kassim, A, Worel, N, Knobler, R, Russell, N, Socie, G. Extracorporeal photopheresis versus anticytokine therapy as a second-line treatment for steroid-refractory acute GVHD: a multicenter comparative analysis. Biol Blood Marrow Transplant, 19(7), 1129-33, 2013.

Vaughan, LA, Vu, M, Sengsayadeth, S, Lucid, C, Clifton, C, McCarty, K, Hagaman, D, Domm, J, Kassim, A, Chinratanalab, W, Goodman, S, Greer, J, Frangoul, H, Engelhardt, BG, Jagasia, M, Savani, BN. New allergies after cord blood transplantation. Cytotherapy, 15(10), 1259-65, 2013.

Wulff-Burchfield, EM, Jagasia, M, Savani, BN. Long-term follow-up of informal caregivers after allo-SCT: a systematic review. Bone Marrow Transplant, 48(4), 469-73, 2013.

Chinratanalab, W, Reddy, N, Greer, JP, Morgan, D, Engelhardt, B, Kassim, A, Brandt, SJ, Jagasia, M, Goodman, S, Savani, BN. Immunomodulatory nonablative conditioning regimen for B-cell lymphoid malignancies. Exp Hematol, 40(6), 431-5, 2012.

Engelhardt, BG, Jagasia, SM, Crowe, JE, Griffith, ML, Savani, BN, Kassim, AA, Lu, P, Weitkamp, JH, Moore, DJ, Yoder, SM, Rock, MT, Jagasia, M. Predicting posttransplantation diabetes mellitus by regulatory T-cell phenotype: implications for metabolic intervention to modulate alloreactivity. Blood, 119(10), 2417-21, 2012.

Engelhardt, BG, Sengsayadeth, SM, Jagasia, M, Savani, BN, Kassim, AA, Lu, P, Shyr, Y, Yoder, SM, Rock, MT, Crowe, JE. Tissue-specific regulatory T cells: biomarker for acute graft-vs-host disease and survival. Exp Hematol, 40(12), 974-982.e1, 2012.

Gunasekaran, U, Agarwal, N, Jagasia, MH, Jagasia, SM. Endocrine complications in long-term survivors after allogeneic stem cell transplant. Semin Hematol, 49(1), 66-72, 2012.

Hart, AJ, Jagasia, MH, Kim, AS, Mosse, CA, Savani, BN, Kassim, A. Minimal residual disease in myeloma: are we there yet. Biol Blood Marrow Transplant, 18(12), 1790-9, 2012.

Jacobs, R, Tran, U, Chen, H, Kassim, A, Engelhardt, BG, Greer, JP, Goodman, SG, Clifton, C, Lucid, C, Vaughan, LA, Savani, BN, Jagasia, M. Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteria. Bone Marrow Transplant, 47(11), 1470-3, 2012.

Jagasia, M, Arora, M, Flowers, ME, Chao, NJ, McCarthy, PL, Cutler, CS, Urbano-Ispizua, A, Pavletic, SZ, Haagenson, MD, Zhang, MJ, Antin, JH, Bolwell, BJ, Bredeson, C, Cahn, JY, Cairo, M, Gale, RP, Gupta, V, Lee, SJ, Litzow, M, Weisdorf, DJ, Horowitz, MM, Hahn, T. Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Blood, 119(1), 296-307, 2012.

Jagasia, M, Clark, WB, Brown-Gentry, KD, Crawford, DC, Fan, KH, Chen, H, Kassim, A, Greer, JP, Engelhardt, BG, Savani, BN. Genetic variation in donor CTLA-4 regulatory region is a strong predictor of outcome after allogeneic hematopoietic cell transplantation for hematologic malignancies. Biol Blood Marrow Transplant, 18(7), 1069-75, 2012.

Jagasia, MH, Abonour, R, Long, GD, Bolwell, BJ, Laport, GG, Shore, TB, Durrant, S, Szer, J, Chen, MG, Lizambri, R, Waller, EK. Palifermin for the reduction of acute GVHD: a randomized, double-blind, placebo-controlled trial. Bone Marrow Transplant, 47(10), 1350-5, 2012.

Reddy, N, Greer, JP, Goodman, S, Engelhardt, B, Oluwole, O, Jagasia, MH, Savani, BN. Long-term outcome after autologous or allogeneic stem cell transplantation in patients with recurrent follicular lymphoma. Bone Marrow Transplant, 47(10), 1318-20, 2012.

Reddy, N, Greer, JP, Goodman, S, Kassim, A, Morgan, DS, Chinratanalab, W, Brandt, S, Englehardt, B, Oluwole, O, Jagasia, MH, Savani, BN. Consolidative therapy with stem cell transplantation improves survival of patients with mantle cell lymphoma after any induction regimen. Exp Hematol, 40(5), 359-66, 2012.

Reddy, N, Oluwole, O, Greer, JP, Goodman, S, Engelhardt, B, Jagasia, MH, Savani, BN. Superior long-term outcome of patients with early transformation of non-Hodgkin lymphoma undergoing stem cell transplantation. Clin Lymphoma Myeloma Leuk, 12(6), 406-11, 2012.

Sengsayadeth, SM, Jagasia, M, Engelhardt, BG, Kassim, A, Strickland, SA, Goodman, S, Lucid, C, Vnencak-Jones, CL, Greer, JP, Savani, BN. Allo-SCT for high-risk AML-CR1 in the molecular era: impact of FLT3/ITD outweighs the conventional markers. Bone Marrow Transplant, 47(12), 1535-7, 2012.

Sengsayadeth, SM, Srivastava, S, Jagasia, M, Savani, BN. Time to explore preventive and novel therapies for bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant, 18(10), 1479-87, 2012.

Clark, WB, Brown-Gentry, KD, Crawford, DC, Fan, KH, Snavely, J, Chen, H, Savani, BN, Kassim, A, Greer, JP, Schuening, FG, Engelhardt, BG, Jagasia, MH. Genetic variation in recipient B-cell activating factor modulates phenotype of GVHD. Blood, 118(4), 1140-4, 2011.

Head, DR, Jacobberger, JW, Mosse, C, Jagasia, M, Dupont, W, Goodman, S, Flye, L, Shinar, A, McClintock-Treep, S, Stelzer, G, Briggs, R, Shults, K. Innovative analyses support a role for DNA damage and an aberrant cell cycle in myelodysplastic syndrome pathogenesis. Bone Marrow Res, 2011, 950934, 2011.

McClintock-Treep, SA, Briggs, RC, Shults, KE, Flye-Blakemore, LA, Mosse, CA, Jagasia, MH, Shinar, AA, Dupont, WD, Stelzer, GT, Head, DR. Quantitative assessment of myeloid nuclear differentiation antigen distinguishes myelodysplastic syndrome from normal bone marrow. Am J Clin Pathol, 135(3), 380-5, 2011.

Jagasia, MH, Savani, BN, Stricklin, G, Engelhardt, B, Kassim, A, Dixon, S, Chen, H, Chinratanalab, W, Goodman, S, Greer, JP, Schuening, F. Classic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP). Biol Blood Marrow Transplant, 15(10), 1288-95, 2009.

Reddy, N, Abel, TW, Jagasia, M, Morgan, D, Weaver, K, Greer, J. Progressive multifocal leukoencephalopathy in a patient with follicular lymphoma treated with multiple courses of rituximab. Leuk Lymphoma, 50(3), 460-2, 2009.

Washington, K, Jagasia, M. Pathology of graft-versus-host disease in the gastrointestinal tract. Hum Pathol, 40(7), 909-17, 2009.

Engelhardt, BG, Holland, DW, Brandt, SJ, Chinratanalab, W, Goodman, SA, Greer, JP, Jagasia, MH, Kassim, AA, Morgan, DS, Ruffner, KL, Schuening, FG, Wolff, S, Bitting, R, Sulur, P, Stein, RS. High-dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin lymphoma: prognostic features and outcomes. Leuk Lymphoma, 48(9), 1728-35, 2007.

Jagasia, M, Giglia, J, Chinratanalab, W, Dixon, S, Chen, H, Frangoul, H, Engelhardt, B, Goodman, S, Greer, J, Kassim, A, Morgan, D, Ruffner, K, Schuening, F. Incidence and outcome of chronic graft-versus-host disease using National Institutes of Health consensus criteria. Biol Blood Marrow Transplant, 13(10), 1207-15, 2007.

Briggs, RC, Shults, KE, Flye, LA, McClintock-Treep, SA, Jagasia, MH, Goodman, SA, Boulos, FI, Jacobberger, JW, Stelzer, GT, Head, DR. Dysregulated human myeloid nuclear differentiation antigen expression in myelodysplastic syndromes: evidence for a role in apoptosis. Cancer Res, 66(9), 4645-51, 2006.

Welch, DC, Wirth, PS, Goldenring, JR, Ness, E, Jagasia, M, Washington, K. Gastric graft-versus-host disease revisited: does proton pump inhibitor therapy affect endoscopic gastric biopsy interpretation. Am J Surg Pathol, 30(4), 444-9, 2006.

Jagasia, MH, Greer, JP, Morgan, DS, Mineishi, S, Kassim, AA, Ruffner, KL, Chen, H, Schuening, FG. Pegfilgrastim after high-dose chemotherapy and autologous peripheral blood stem cell transplant: phase II study. Bone Marrow Transplant, 35(12), 1165-9, 2005.

Jagasia, M, Morgan, D, Goodman, S, Hamilton, K, Kinney, M, Shyr, Y, Stein, R, Zic, J, Greer, J. Histology impacts the outcome of peripheral T-cell lymphomas after high dose chemotherapy and stem cell transplant. Leuk Lymphoma, 45(11), 2261-7, 2004.

Johnson, MD, Aulino, JP, Jagasia, M, Mawn, LA. Erdheim-chester disease mimicking multiple meningiomas syndrome. AJNR Am J Neuroradiol, 25(1), 134-7, 2004.

Pereira Neto, CC, Roman, C, Johnson, M, Jagasia, M, Martin, WH, Delbeke, D. Positron emission tomography/computed tomography of a rare xanthogranulomatous process: Erdheim-Chester disease. Mol Imaging Biol, 6(1), 63-7, 2004.

Arrowsmith, ER, Macon, WR, Kinney, MC, Stein, RS, Goodman, SA, Morgan, DS, Flexner, JM, Cousar, JB, Jagasia, MH, McCurley, TL, Greer, JP. Peripheral T-cell lymphomas: clinical features and prognostic factors of 92 cases defined by the revised European American lymphoma classification. Leuk Lymphoma, 44(2), 241-9, 2003.

Jagasia MH, Langer CJ, Johnson DH, Yunus F, Rodgers JS, Schlabach LL, CohenAG, Shyr Y, Carbone DP, DeVore RF . Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: A phase II multicenter study. Clinical Cancer Research, January, , 2001.

Jagasia, MH, Langer, CJ, Johnson, DH, Yunus, F, Rodgers, JS, Schlabach, LL, Cohen, AG, Shyr, Y, Carbone, DP, Devore, RF. Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: a multicenter phase II study. Clin Cancer Res, 7(1), 68-73, 2001.

Stein RS, Wolff SN, Greer JP, Flexner JM, Goodman S, Jagasia M, Brandt SJ, Morgan DS, Arrowsmith E, McCurley TL. Age and cytogenetics as predictors of event free survival in patients with acute non-lymphocytic leukemia receiving high dose cytosine arabinoside and daunorubicin as consolidation chemotherapy. Leuk Lymp, (42), 913-922, 2001.

Stein, RS, Wolff, SN, Greer, JP, Flexner, JM, Goodman, S, Jagasia, M, Brandt, SJ, Morgan, DS, Arrowsmith, E, McCurley, TL. Age and cytogenetics as predictors of event free survival in patients with acute non-lymphocytic leukemia receiving high dose cytosine arabinoside and daunorubicin as consolidation chemotherapy. Leuk Lymphoma, 42(5), 913-22, 2001.

Choy H, Chakravarthy A, DeVore RF, Jagasia MH, Hande K, Roberts JR, Johnson DH. Weekly irinotecan and concurrent radiation therapy for stage III unresectable non-small cell lung cancer. Oncology. Suppl, (5, July), , 2000.

Choy, H, Chakravarthy, A, Devore, RF, Jagasia, M, Hande, KR, Roberts, JR, Johnson, DH, Yunus, F. Weekly irinotecan and concurrent radiation therapy for stage III unresectable NSCLC. Oncology (Williston Park), 14(7 Suppl 5), 43-6, 2000.

DeVore RF III, Jagasia MH, Johnson DH. Paclitaxel by either 1-hour or 24-hour infusion in combination with carboplatin in advanced non-small cell lung cancer: preliminary results comparing sequential phase II trials. Semin.Oncol, (24), S12-S12, 1997.

DeVore, RF, Jagasia, M, Johnson, DH. Paclitaxel by either 1-hour or 24-hour infusion in combination with carboplatin in advanced non-small cell lung cancer: preliminary results comparing sequential phase II trials. Semin Oncol, 24(4 Suppl 12), S12-27-S12-29, 1997.

Jagasia MH, Cole FH, Stegman MH, Deaton P, Kennedy L. Video-assisted talc pleurodesis in the management of pleural effusion secondary to continuous ambulatory peritoneal dialysis: a report of three cases. Am.J.Kidney Dis, (28), 772-774, 1996.


Postdoctoral Position Available
No

Postdoctoral Position Details
N/A

Updated Date
01/09/2007



Vanderbilt University is committed to principles of equal opportunity and affirmative action.
Copyright 2008 Vanderbilt University School of Medicine
The office of Biomedical Research Education & Training All rights reserved.
For questions or problems concerning this page, please submit a help ticket.